Focusing on Diabetic Foot Prevention and Control, Building a Healthy Barrier Together

       Diabetic foot, as one of the most severe chronic complications of diabetes, is a "silent killer" threatening patients' health due to its high incidence rate, high disability rate, and high recurrence rate. To consolidate diagnostic and treatment consensus and promote standardized protocols, the "2025 Annual Meeting of the Diabetes Foot Professional Committee of the Jilin Health Digital Research Association, the 11th Jilin Multidisciplinary Diabetes Foot Diagnosis and Treatment Forum, and the Bethune·Diabetes Full-Course Standardized Management Salon Project," jointly organized by the Jilin Health Digital Research Association and the Jilin Provincial People's Hospital, was grandly held at the Jilin Provincial People's Hospital on December 13, 2025.

Deepening Clinical Expertise, Interpreting Industry Trends

       This conference brings together senior experts and scholars in the field of diabetic foot diagnosis and treatment from across the province and even the nation. Leveraging their profound clinical experience and forward-looking industry insights, they engage in in-depth discussions on core topics surrounding diabetic foot diagnosis, treatment, and management. The lecture content closely aligns with clinical practical needs, systematically organizing fundamental diagnostic and therapeutic logic while also providing deep insights into industry trends. It effectively conveys practical knowledge and cutting-edge concepts to the medical professionals present, making this academic exchange a vital platform for fostering industry consensus and expanding diagnostic perspectives.

Focusing on wound care, supporting diabetic foot diagnosis and treatment practices

       Focusing on the advancement of wound care technology, this conference showcased key products from Levor Medical tailored for diabetic foot clinical diagnosis and treatment. Among them, the biological colloidal dispersant not only meets high-standard surgical requirements but also boasts dual core advantages of broad-spectrum antibacterial properties and active wound-healing promotion, demonstrating extensive clinical potential in modern wound care, particularly for complex chronic ulcers like diabetic foot. Another product, the seaweed-based biological adhesive, forms a physical protective layer over the wound surface, effectively reducing exudation and alleviating irritation while offering anti-inflammatory, pain-relieving, and accelerated healing benefits, creating a stable, moist environment conducive to wound recovery.

       These products precisely align with the core theme of this conference, "Diagnosis and Management of Diabetic Foot." Through on-site product demonstrations and professional technical presentations, they attracted the attention and engagement of numerous attending experts and clinical colleagues, providing specialized and practical solutions for the clinical care of diabetic foot ulcers.

Mission Together, Painting a New Picture of Health

       All technical discussions and academic explorations ultimately aim for the well-being of patients and the dignity of life. While deepening diagnostic and treatment consensus, this conference has also crystallized this original intent into clear directions of action. The true value of academic contributions lies in transforming consensus into practice. Laiwo Medical looks forward to collaborating with all clinical colleagues to implement cutting-edge concepts and practical technologies effectively. Through more precise collaboration and warmer management, we will jointly build a more efficient and standardized regional prevention and treatment system for diabetic foot, ensuring the safeguarding of every patient's foot health journey.